NEXTSTELLIS (Mayne Pharma International Pty Ltd)
Product name
NEXTSTELLIS
Date registered
Evaluation commenced
Decision date
Approval time
200 (255 working days)
Active ingredients
estetrol monohydrate; drospirenone
Registration type
NCE/NBE
Indication
NEXTSTELLIS (film-coated tablet) is indicated for use by women of reproductive potential to prevent pregnancy.